| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/01/2011 | US20110212985 Naltrexone Long Acting Formulations and Methods of Use |
| 09/01/2011 | US20110212912 Optimised formulation of tobramycin for aerosolization |
| 09/01/2011 | US20110212884 Guanylate cyclase receptor agonists for the treatment of tissue inflammation and carcinogenesis |
| 09/01/2011 | US20110212243 Parenteral selenomethionine for production of selenium-rich foods |
| 09/01/2011 | US20110212182 Masked taste pharmaceutical granules/granulates |
| 09/01/2011 | US20110212181 Compositions and methods for treating chronic respiratory inflammation |
| 09/01/2011 | US20110212180 Method of producing microcapsules |
| 09/01/2011 | US20110212179 Micro-spherical porous biocompatible scaffolds and methods and apparatus for fabricating same |
| 09/01/2011 | US20110212178 Injectable Hydrogel Filaments For Biomedical Uses |
| 09/01/2011 | US20110212177 Configurable microscopic medical payload delivery device to deliver medically therapeutic payloads to specifically targeted cell types |
| 09/01/2011 | US20110212176 Ciclopirox and cytarabine for the treatment of leukemic disorders |
| 09/01/2011 | US20110212175 Combination preparation comprising angiotensin-ii-receptor blocker and hmg-coa reductase inhibitor |
| 09/01/2011 | US20110212174 Controlled release arginine formulations |
| 09/01/2011 | US20110212173 Controlled Release Treatment of Depression |
| 09/01/2011 | US20110212172 Administration of an adsorbent polymer for treatment of systemic inflammation |
| 09/01/2011 | US20110212171 Taste masked topiramate composition and an orally disintegrating tablet comprising the same |
| 09/01/2011 | US20110212170 Formulation For Retinoid-Containing Soft Gelatin Capsules |
| 09/01/2011 | US20110212169 METHOD FOR PRODUCING POWDER CONTAINING NANOPARTICULATED SPARINGLY SOLUBLE DRUG, POWDER PRODUCED THEREBY AND PHARMACEUTICAL COMPOSITION CONTAINING SAME (As Amended) |
| 09/01/2011 | US20110212168 Composition for targeting dendritic cells |
| 09/01/2011 | US20110212167 Lipid based pharmaceutical preparations for oral and topical application; their compositions, methods, and uses thereof |
| 09/01/2011 | US20110212166 Carnitine conjugates of adamantanamines derivatives as dual prodrugs for various uses |
| 09/01/2011 | US20110212165 Pharmaceutical compositions of the isolated d-enantiomer of the quinazolinone derivative halofuginone |
| 09/01/2011 | US20110212164 Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof |
| 09/01/2011 | US20110212163 Magnetic heating for drug delivery and other applications |
| 09/01/2011 | US20110212162 Lymphatic zip codes in tumors and pre-malignant lesions |
| 09/01/2011 | US20110212161 Treatment skin disorders |
| 09/01/2011 | US20110212160 Configurable microscopic medical payload delivery device to deliver nuclear signaling proteins to specific cells to manage diabetes mellitus and genetic deficiency disorders |
| 09/01/2011 | US20110212159 Vaccines |
| 09/01/2011 | US20110212158 Immunocompatible chorionic membrane products |
| 09/01/2011 | US20110212157 Dermal delivery |
| 09/01/2011 | US20110212156 Use of a mixture of two or more enteric materials to regulate drug release via membrance or matrix for systemic therapeutics |
| 09/01/2011 | US20110212153 Composite coatings and deposition methods |
| 09/01/2011 | US20110212152 Modified anti-microbial surfaces, devices and methods |
| 09/01/2011 | US20110212150 Process for the treatment of cellulosic molded bones |
| 09/01/2011 | US20110212149 Puffed starch material |
| 09/01/2011 | US20110212146 Compositions |
| 09/01/2011 | US20110212142 Curcuminoids and its metabolites for the application in ocular diseases |
| 09/01/2011 | US20110212141 Injectable depot formulation comprising crystals of iloperidone |
| 09/01/2011 | US20110212140 Pressure-sensitive adhesive composition applicable to nail and adhesive agent for nail |
| 09/01/2011 | US20110212138 Sustained release formulations using non-aqueous carriers |
| 09/01/2011 | US20110212137 Inhalable pharmaceutical composition |
| 09/01/2011 | US20110212136 Nanosphere/Microsphere Delivery System for the Treatment of Spinal Cord Injury |
| 09/01/2011 | US20110212035 Emollient foams for treatment of dermatoses |
| 09/01/2011 | US20110212034 Sublingual Buccal Effervescent |
| 09/01/2011 | US20110212033 Oil and liquid silicone foamable carriers and formulations |
| 09/01/2011 | US20110212030 Nucleic Acid Ligand Complexes |
| 09/01/2011 | US20110210460 Process for producing pellets for pharmaceutical compositions |
| 09/01/2011 | US20110209699 Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a lipoxygenase inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| 09/01/2011 | DE10320604B4 Partikel umfassend ein Biopolymer, das unter Einwirkung von elektromagnetischen Wellen, ausgestrahlt durch Sonneneinstrahlung, abbaubar ist Particles comprising a biopolymer that is under the influence of electromagnetic waves emitted by the sun, degradable |
| 09/01/2011 | DE102010009475A1 Verfahren zur Herstellung eines dosierbaren applikationsfertigen Präparates A method for producing a metered the ready preparation |
| 09/01/2011 | CA2791278A1 Sustained delivery of therapeutic agents to an eye compartment |
| 09/01/2011 | CA2791196A1 Adhesive skin patch |
| 09/01/2011 | CA2791171A1 Apixaban formulations |
| 09/01/2011 | CA2791164A1 Adhesive patch containing bisoprolol |
| 09/01/2011 | CA2791014A1 Emollient foams for treatment of dermatoses |
| 09/01/2011 | CA2790978A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 09/01/2011 | CA2790918A1 Pharmaceutical or neutraceutical formulation |
| 09/01/2011 | CA2790895A1 Protein formulations |
| 09/01/2011 | CA2790817A1 Solid pharmaceutical formulations of ramipril and amlodipine besylate, and their preparation |
| 09/01/2011 | CA2790811A1 Formulations for oral delivery of adsorbents in the gut |
| 09/01/2011 | CA2790108A1 Abuse-resistant formulations |
| 09/01/2011 | CA2789320A1 Method and apparatus for preparing liposomes using supercritical fluid |
| 09/01/2011 | CA2789064A1 Capsule of compound danshen dripping pills |
| 09/01/2011 | CA2788659A1 Veterinary compositions |
| 09/01/2011 | CA2788440A1 Pharmaceutical compositions of spiro-oxindole compound for topical administration and their use as therapeutic agents |
| 09/01/2011 | CA2785694A1 Coated solid montelukast preparation |
| 08/31/2011 | EP2361981A1 RNA sequence-specific mediators of RNA interference |
| 08/31/2011 | EP2361918A1 Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein |
| 08/31/2011 | EP2361637A1 Formulation of human antibodies for treating TNF-alpha associated disorders |
| 08/31/2011 | EP2361636A1 Immunoglobulin preparation and storage system for an immunoglobulin preparation |
| 08/31/2011 | EP2361630A1 Implantable drug delivery device comprising particles and an osmotic pump |
| 08/31/2011 | EP2361617A1 Sustained release intraocular implants comprising a beta adrenergic receptor antagonist and methods for treating ocular neuropathies |
| 08/31/2011 | EP2361616A1 Extended release compositions for high solubility, high permeability active pharmaceutical ingredients |
| 08/31/2011 | EP2361615A1 Dipyridamole prolonged-release tablet |
| 08/31/2011 | EP2361614A2 Fast dissolving oral tablets and method for production thereof |
| 08/31/2011 | EP2361613A1 Stabilized compositions of proteins having a free thiol moiety |
| 08/31/2011 | EP2361612A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 08/31/2011 | EP2361611A2 Aqueous sustained-release drug delivery system for highly water-soluble electrolytic drugs |
| 08/31/2011 | EP2361610A1 Ophthalmic compositions containing a synergistic combination of two polymers |
| 08/31/2011 | EP2361609A1 Sustained release small molecule drug formulation |
| 08/31/2011 | EP2361502A1 Active antimicrobial compositions, coatings and methods for controlling pathogenic bacteria |
| 08/31/2011 | EP2361127A1 Systems and methods for modeling of crystallization processes |
| 08/31/2011 | EP2361092A1 Health care |
| 08/31/2011 | EP2361090A1 Compositions for treating centrally mediated nausea and vomiting |
| 08/31/2011 | EP2361084A2 Electrostatically charged multi-acting nasal application, product, and method |
| 08/31/2011 | EP2361083A1 Composition for treatment of epithelial tissue |
| 08/31/2011 | EP2361082A1 Coated tablets with a remaining degradation surface over the time |
| 08/31/2011 | EP2361081A1 Multi portion intra-oral dosage form and use thereof |
| 08/31/2011 | EP2361080A1 Dental appliance cleanser |
| 08/31/2011 | EP2361055A1 Improved bolus |
| 08/31/2011 | EP2361053A1 Improvements in bolus devices for the delivery of active agents to animals |
| 08/31/2011 | EP2217208B1 Nucleic acid complex and nucleic acid delivery composition |
| 08/31/2011 | EP2120890B1 Coated pellets |
| 08/31/2011 | EP2029110B1 Process for preparing spray dried formulations of tmc125 |
| 08/31/2011 | EP1660037B1 Aripiprazole injectable suspension |
| 08/31/2011 | EP1634589B9 Aqueous olanexidine solution, method of preparing the same, and disinfectant |
| 08/31/2011 | EP1523325B1 Methods and compositions for treating polycystic ovary syndrome |
| 08/31/2011 | EP1523305B1 Device and patch for controlling the release of vanillin |
| 08/31/2011 | EP1467712B2 Method of producing a bilayer pharmaceutical tablet comprising telmisartan and hydrochlorothiazide |
| 08/31/2011 | EP1460060B2 Method of obtaining novel lutein-based formulations |